ArticleJournal of clinical and translational hepatology2017

Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.

Channa R Jayasekera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.